WO2010041892A3 - Aimp1 폴리펩티드의 신규한 용도 - Google Patents

Aimp1 폴리펩티드의 신규한 용도 Download PDF

Info

Publication number
WO2010041892A3
WO2010041892A3 PCT/KR2009/005778 KR2009005778W WO2010041892A3 WO 2010041892 A3 WO2010041892 A3 WO 2010041892A3 KR 2009005778 W KR2009005778 W KR 2009005778W WO 2010041892 A3 WO2010041892 A3 WO 2010041892A3
Authority
WO
WIPO (PCT)
Prior art keywords
diagnosis
rheumatoid arthritis
aimp1
specimen
aimp1 polypeptide
Prior art date
Application number
PCT/KR2009/005778
Other languages
English (en)
French (fr)
Other versions
WO2010041892A2 (ko
WO2010041892A9 (ko
Inventor
김성훈
한정민
Original Assignee
서울대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 서울대학교산학협력단 filed Critical 서울대학교산학협력단
Priority to US13/123,511 priority Critical patent/US20110250701A1/en
Priority to EP09819399.8A priority patent/EP2348049B1/en
Publication of WO2010041892A2 publication Critical patent/WO2010041892A2/ko
Publication of WO2010041892A9 publication Critical patent/WO2010041892A9/ko
Publication of WO2010041892A3 publication Critical patent/WO2010041892A3/ko

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints

Abstract

본 발명은 AIMP1 폴리펩티드의 신규한 용도에 관한 것으로, 보다 상세하게는 AIMP1에 대한 항체를 포함하는 관절염 진단용 조성물, 이를 포함하는 진단 키트, 개체로부터 검체(specimen)를 수득하는 단계; 및 상기 검체에 포함된 AIMP1 폴리펩티드를 검출하는 단계를 포함하는 것을 특징으로 하는 관절염 진단방법 및 관절염 진단을 위한 AIMP1 폴리펩티드에 대한 항체에 관한 것이다. 본 발명은 관절염에 대한 신규한 진단 마커로서, AIMP1 폴리펩티드에 대한 항체를 포함하는 관절염 진단용 조성물, 이를 포함하는 진단 키트, 개체로부터 검체(specimen)를 수득하는 단계; 및 상기 검체에 포함된 AIMP1 폴리펩티드를 검출하는 단계를 포함하는 것을 특징으로 하는 관절염 진단방법 및 관절염 진단을 위한 AIMP1 폴리펩티드에 대한 항체를 제공한다. 본 발명의 조성물, 진단 키트, 진단 방법 및 AIMP1 폴리펩티드에 대한 항체는 환자의 시료로부터 손쉽게 관절염 여부를 진단할 수 있으므로 관절염의 조기 진단 및 확정을 위하여 사용할 수 있다.
PCT/KR2009/005778 2008-10-10 2009-10-09 Aimp1 폴리펩티드의 신규한 용도 WO2010041892A2 (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US13/123,511 US20110250701A1 (en) 2008-10-10 2009-10-09 Novel application of aimp1 polypeptide
EP09819399.8A EP2348049B1 (en) 2008-10-10 2009-10-09 Application of aimp1 polypeptide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2008-0099782 2008-10-10
KR1020080099782A KR101067817B1 (ko) 2008-10-10 2008-10-10 Ａｉｍｐ1 폴리펩티드에 대한 항체를 포함하는 관절염 진단용 조성물

Publications (3)

Publication Number Publication Date
WO2010041892A2 WO2010041892A2 (ko) 2010-04-15
WO2010041892A9 WO2010041892A9 (ko) 2010-07-01
WO2010041892A3 true WO2010041892A3 (ko) 2010-08-19

Family

ID=42101102

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/005778 WO2010041892A2 (ko) 2008-10-10 2009-10-09 Aimp1 폴리펩티드의 신규한 용도

Country Status (4)

Country Link
US (1) US20110250701A1 (ko)
EP (1) EP2348049B1 (ko)
KR (1) KR101067817B1 (ko)
WO (1) WO2010041892A2 (ko)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2727622A1 (en) * 2008-06-11 2009-12-17 Atyr Pharma, Inc. Thrombopoietic activity of tyrosyl-trna synthetase polypeptides
JP5756751B2 (ja) 2008-06-26 2015-07-29 エータイアー ファーマ， インコーポレイテッド 非正準的な生物学的活性を有するグリシル−ｔＲＮＡ合成酵素を含む組成物および方法
US20120004185A1 (en) 2009-02-27 2012-01-05 Atyr Pharma, Inc. Polypeptide structural motifs associated with cell signaling activity
DK3255146T3 (da) 2009-03-16 2019-08-19 Pangu Biopharma Ltd Præparater og fremgangsmåder omfattende histidyl-tRNA-synthetasesplejsningsvarianter med ikke-kanoniske biologiske aktiviteter
AU2010236913B2 (en) * 2009-03-31 2016-03-24 Atyr Pharma, Inc. Compositions and methods comprising aspartyl-tRNA synthetases having non-canonical biological activities
US8828395B2 (en) 2009-12-11 2014-09-09 Atyr Pharma, Inc. Antibodies that bind tyrosyl-tRNA synthetases
EP2509625B1 (en) 2009-12-11 2015-01-28 Atyr Pharma, Inc. Histidyl trna synthetases for reducing inflammation
WO2011072266A2 (en) * 2009-12-11 2011-06-16 Atyr Pharma, Inc. Aminoacyl trna synthetases for modulating hematopoiesis
KR101150900B1 (ko) * 2010-01-26 2012-05-30 연세대학교 산학협력단 퇴행성 관절염 치료 조성물
AU2011248625B2 (en) 2010-04-26 2017-01-05 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
JP6294074B2 (ja) 2010-04-27 2018-03-14 エータイアー ファーマ， インコーポレイテッド イソロイシルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
JP6240500B2 (ja) 2010-04-27 2017-11-29 エータイアー ファーマ， インコーポレイテッド スレオニルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
CA2797271C (en) 2010-04-28 2021-05-25 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
CN103097523B (zh) 2010-04-29 2016-09-28 Atyr医药公司 与天冬酰胺酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
CA2797393C (en) 2010-04-29 2020-03-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
ES2668207T3 (es) 2010-05-03 2018-05-17 Atyr Pharma, Inc. Descubrimiento innovador de composiciones terapéuticas, de diagnóstico y de anticuerpos relacionadas con fragmentos de proteínas de metionil-ARNt sintetasas
CN103096925A (zh) 2010-05-03 2013-05-08 Atyr医药公司 与精氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
AU2011248227B2 (en) 2010-05-03 2016-12-01 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
JP6039546B2 (ja) 2010-05-03 2016-12-07 エータイアー ファーマ， インコーポレイテッド セリルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
CN102985103A (zh) 2010-05-04 2013-03-20 Atyr医药公司 与p38多-tRNA合成酶复合物相关的治疗、诊断和抗体组合物的创新发现
CN103096909A (zh) 2010-05-04 2013-05-08 Atyr医药公司 与谷氨酰-脯氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
US8945541B2 (en) 2010-05-14 2015-02-03 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases
CA2799480C (en) 2010-05-17 2020-12-15 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases
EP2575856B1 (en) 2010-05-27 2017-08-16 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
EP2575857B1 (en) 2010-06-01 2018-01-24 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
CA2804278C (en) 2010-07-12 2021-07-13 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases
US8999321B2 (en) 2010-07-12 2015-04-07 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
WO2012021247A2 (en) 2010-07-12 2012-02-16 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
JP6177129B2 (ja) 2010-07-12 2017-08-09 エータイアー ファーマ， インコーポレイテッド ヒスチジルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
CA2808539C (en) 2010-08-25 2021-05-25 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases
US9399770B2 (en) 2010-10-06 2016-07-26 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tryptophanyl-tRNA synthetases
KR101589135B1 (ko) * 2011-04-20 2016-01-29 주식회사 셀앤바이오 인간화 항-ｅｍａｐｉｉ 항체 및 이의 용도
US9714419B2 (en) 2011-08-09 2017-07-25 Atyr Pharma, Inc. PEGylated tyrosyl-tRNA synthetase polypeptides
WO2013086228A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Pegylated aspartyl-trna synthetase polypeptides
WO2013086216A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Improved aspartyl-trna synthetases
AU2012368189B2 (en) 2011-12-29 2017-08-31 Atyr Pharma, Inc. Aspartyl-tRNA synthetase-Fc conjugates
WO2013105721A1 (ko) * 2012-01-13 2013-07-18 가톨릭대학교 산학협력단 류마티스 관절염 진단 키트
US9347941B2 (en) 2012-01-13 2016-05-24 Catholic University Industry-Academic Cooperation Foundation Diagnosis kit for rheumatoid arthritis
US8835387B2 (en) 2012-02-16 2014-09-16 Atyr Pharma, Inc. Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
ES2708565T3 (es) 2013-03-15 2019-04-10 Atyr Pharma Inc Conjugados de Fc-histidil-ARNt sintetasa
JP6792001B2 (ja) * 2016-07-01 2020-11-25 メディシナル バイオコンバージェンス リサーチ センター アミノアシルｔＲＮＡ合成酵素関連タンパク質発現水準を利用した甲状腺瀘胞癌診断用組成物と診断マーカー検出方法
KR101757346B1 (ko) * 2017-03-27 2017-07-26 아주대학교산학협력단 항-emap ii 항체 및 이의 용도
WO2018195338A1 (en) 2017-04-20 2018-10-25 Atyr Pharma, Inc. Compositions and methods for treating lung inflammation
KR20180121057A (ko) * 2017-04-28 2018-11-07 아주대학교산학협력단 Aimp1을 포함하는 전신 홍반성 루프스 진단용 바이오마커 조성물 및 이를 이용한 전신 홍반성 루프스 진단 방법
KR102118631B1 (ko) * 2019-09-30 2020-06-03 조선대학교 산학협력단 관절염 진단용 조성물 및 이를 포함하는 키트

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001095927A1 (en) * 2000-06-14 2001-12-20 Imagene Co., Ltd. P43 anti-tumor therapeutic agent and three dimensional structure of its cytokine domain
EP1384486A1 (en) * 2002-07-22 2004-01-28 Seoul National University Industry Foundation Use of p43 for stimulating wound healing

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641867A (en) * 1993-09-29 1997-06-24 The Trustees Of Columbia University In The City Of New York Antibody which specifically binds to endothelial-monocyte activating polypeptide II
EP2006681A4 (en) * 2006-03-02 2009-07-01 Univ Chiba Nat Univ Corp TEST METHOD AND METHOD FOR TREATING RHEUMATOID ARTHRITIS
WO2008007818A1 (en) * 2006-07-13 2008-01-17 Seoul National University Industry Foundation Novel use of aimp1 for controlling glucose level
CN101688230A (zh) * 2007-04-27 2010-03-31 伊玛吉恩有限公司 免疫调节剂的筛选方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001095927A1 (en) * 2000-06-14 2001-12-20 Imagene Co., Ltd. P43 anti-tumor therapeutic agent and three dimensional structure of its cytokine domain
EP1384486A1 (en) * 2002-07-22 2004-01-28 Seoul National University Industry Foundation Use of p43 for stimulating wound healing

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
HAN, J. M. ET AL.: "Aminoacyl-tRNA synthetase-interacting multifunctional protein 1/p43 controls endoplasmic reticulum retention of heat shock protein gp96:its pathological implications in lupus-like autoimmune disease.", AMERICAN JOURNAL OF PATHOLOGY., vol. 170, no. 6, June 2007 (2007-06-01), pages 2042 - 2054, XP008136864 *
KIM, E. ET AL.: "AIMP1/p43 protein induces the maturation of bone marrow-derived dendritic cells with T-helper type 1-polarizing ability.", JOURNAL OF IMMUNOLOGY, vol. 180, no. 5, 1 March 2008 (2008-03-01), pages 2894 - 2902, XP008136870 *
KIM. T. S. ET AL.: "Gene transfer of AIMP1 and B7. 1 into epitope-loaded, fibroblasts induces tumor-specific CTL immunity, and prolongs the survival period of tumor-bearing mice.", VACCINE., vol. 26, no. 47, 13 September 2008 (2008-09-13), pages 5928 - 5934, XP025613276 *
KO, Y. G. ET AL.: "A cofactor oftRNA synthetase, p43, is secreted to up-regulated proinflammatory genes.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 276, no. 25, 5 April 2001 (2001-04-05), pages 23028 - 23033, XP008120067 *
See also references of EP2348049A4 *

Also Published As

Publication number Publication date
WO2010041892A2 (ko) 2010-04-15
EP2348049A4 (en) 2012-03-28
WO2010041892A9 (ko) 2010-07-01
KR20100040582A (ko) 2010-04-20
US20110250701A1 (en) 2011-10-13
EP2348049A2 (en) 2011-07-27
KR101067817B1 (ko) 2011-09-27
EP2348049B1 (en) 2013-10-02

Similar Documents

Publication Publication Date Title
WO2010041892A3 (ko) Aimp1 폴리펩티드의 신규한 용도
WO2010090471A3 (ko) 제1형 당뇨병의 신규한 진단 마커
NZ602056A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2012021407A3 (en) Biomarkers for stroke
WO2006090389A3 (en) Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
WO2009113814A3 (ko) 간암 진단용 단백질성 마커
WO2012021795A3 (en) Pancreatic cancer biomarkers and uses thereof
WO2008089072A3 (en) Proteomic profiling method useful for condition diagnosis and monitoring, composition screening, and therapeutic monitoring
WO2008111464A1 (ja) スプライシング異常を指標とする抗ガン剤の作用検定方法
NZ609824A (en) Immunochromatography devices, methods and kits
EP2021794B8 (en) Use of protein s100a 12 as a marker for colorectal cancer
WO2009144424A3 (fr) Procede et methodes de diagnostic de la maladie d'alzheimer
WO2007119111A3 (en) Tissue diagnostics for ovarian cancer
WO2007114986A3 (en) Cooperative probes and methods of using them
WO2010092164A3 (en) Bacterial dna as markers of cardiovascular and/or metabolic disease
WO2011071364A3 (en) A specimen collecting and testing apparatus
WO2007024735A3 (en) Method and antibodies for detecting nitrofuran
WO2012032345A3 (en) Biomarker signatures and uses thereof
WO2007132120A3 (fr) Procede et methodes de detection de la maladie d'alzheimer
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
ATE500503T1 (de) Cd86- und cd80-rezeptorkonkurrenztests
WO2011074802A3 (ko) 전립선암 진단용 키트 및 진단방법
WO2011044125A8 (en) A method for diagnosing primary biliary cirrhosis (pbc) using novel autoantigens
WO2011109112A3 (en) Method of detecting tau protein and tau fragments in serum
WO2012034130A3 (en) Methods and compositions for nucleic acid detection

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09819399

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009819399

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 13123511

Country of ref document: US